Superficial cerebral veins
Superficial cerebral veins are veins that drain the outermost part of the brain, known as the cerebral cortex. They are part of the venous system of the brain, which is responsible for removing deoxygenated blood and waste products from the brain tissue.
Etymology[edit]
The term "superficial" comes from the Latin word "superficialis", which means "pertaining to the surface". The term "cerebral" comes from the Latin word "cerebrum", which means "brain". The term "vein" comes from the Latin word "vena", which means "blood vessel".
Structure[edit]
Superficial cerebral veins are located on the surface of the brain, specifically on the cerebral cortex. They are responsible for draining deoxygenated blood and waste products from the brain tissue and transporting them to the dural venous sinuses, which are large veins located within the dura mater, one of the protective layers of the brain.
There are several superficial cerebral veins, including the superior anastomotic vein, also known as the vein of Trolard, and the inferior anastomotic vein, also known as the vein of Labbé. These veins are named after the French physicians who first described them, Louis Théophile Joseph Landouzy and Paul Labbé, respectively.
Function[edit]
The primary function of the superficial cerebral veins is to drain deoxygenated blood and waste products from the brain tissue. This is an essential function, as it helps to maintain the health and function of the brain by removing waste products and providing a pathway for the return of deoxygenated blood to the heart.
Clinical significance[edit]
Dysfunction or damage to the superficial cerebral veins can lead to serious medical conditions, such as cerebral venous sinus thrombosis, which is a type of stroke caused by a blood clot in the dural venous sinuses. This condition can cause symptoms such as headache, seizures, and neurological deficits, and requires immediate medical attention.
See also[edit]
References[edit]
<references />
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


